Who needs SFDA medical device marketing authorisation?
In Saudi Arabia, medical devices, in-vitro diagnostic (IVD) devices and their accessories are regulated by the Saudi Food and Drug Authority (SFDA) under the Medical Devices Law and its implementing regulations. Before a device can be imported, distributed or sold, it generally needs a Medical Device Marketing Authorization (MDMA) from SFDA. The scope is broad, from syringes and gloves to imaging equipment, implants, dental materials, laboratory analysers, test kits and medical software.
Scope matters especially for aesthetic manufacturers. Lasers, IPL, radiofrequency and HIFU systems, dermal fillers, PDO threads and many microneedling products are usually regulated as medical devices, not cosmetics. A skin-care cream may follow SFDA cosmetics notification; a filler or laser does not.
The Saudi Authorized Representative (AR)
A foreign manufacturer typically creates an SFDA account but cannot manage the Saudi authorisation alone. SFDA requires an Authorized Representative established in Saudi Arabia, holding an SFDA AR licence and appointed through a formal mandate. The AR is the manufacturer's legal contact with the authority: it submits applications, keeps documentation available and supports safety and post-market duties.
- One AR per device: SFDA generally does not allow more than one Authorized Representative for the same device, so the choice deserves care
- Licensed entity: the AR must hold a valid SFDA licence, which is renewed periodically
- Separate from distribution: the AR can be your distributor, your own Saudi subsidiary or an independent licensed company, and each option has commercial consequences
Many Korean, Turkish and Chinese manufacturers start with a distributor acting as AR, then move the role to a neutral party or their own entity. Changing the AR later means updating SFDA records, so plan early. For your own entity, see our guide to investing in Saudi Arabia.
Risk classification of medical devices and IVDs
SFDA classifies devices by risk, generally from Class A (lowest) to Class D (highest), with dedicated rules for IVDs. Classification depends on intended purpose, duration of body contact, invasiveness and whether the device is active; for IVDs it reflects the risk of an incorrect result. The class drives the depth of review, the evidence expected and the likely timeline.
- Lower-risk devices usually involve a lighter file but still need SFDA registration
- Implants, active therapeutic devices and many high-risk IVDs face deeper technical and clinical review
- Your EU or US class is a useful starting point, but the Saudi class must be confirmed under SFDA rules
Reference-country approvals and the MDMA file
Applications are submitted electronically through SFDA systems, currently the GHAD platform for licensing and marketing authorisation services. SFDA generally takes into account prior approvals from recognised reference regulators, such as EU CE marking, US FDA clearance or approval, and approvals in Australia, Canada or Japan. This usually makes the pathway smoother but does not replace the SFDA review. Without a reference approval, the route is typically more demanding and should be checked with SFDA.
A typical MDMA file includes:
- Proof of reference approvals where available, plus the AR mandate
- Device description, intended use, classification rationale and the list of models or variants
- Technical documentation covering essential principles of safety and performance, risk management and design verification
- Quality management system evidence, usually an ISO 13485 certificate
- Clinical evidence or, for IVDs, analytical and clinical performance data suited to the risk class
- Labels, instructions for use and the declaration of conformity, with sterilisation, biocompatibility, software or electrical safety reports where relevant
Practical tip: keep model names, catalogue numbers and intended-use wording identical across CE or FDA documents, labels, IFU and the SFDA submission. Inconsistencies are a common cause of queries.
Arabic labelling and instructions for use
SFDA expects key labelling information in Arabic, often alongside English: device name, manufacturer and AR details, lot or serial number, expiry date where relevant, storage conditions, warnings and instructions for use. Professional-use devices may have some flexibility on detailed manuals, while home-use devices usually need full Arabic instructions. SFDA has also been introducing unique device identification (UDI) requirements. We prepare and review Arabic translations so medical terminology is accurate.
Establishment licences, importers and the national registry
The MDMA authorises the device; it does not on its own authorise a company to import, store or sell it. Saudi importers, distributors and warehouses generally need an SFDA medical device establishment licence, and their premises may be inspected. Authorised devices are recorded in SFDA's Medical Device National Registry (MDNR), and customs clearance usually checks that both the device and the importer are properly registered. Medical devices are regulated by SFDA rather than SABER, although non-medical items in the same shipment may fall under SASO rules.
Foreign manufacturers therefore align three parties: manufacturer, Authorized Representative and licensed importer. When formalising a distributor relationship, some companies also consider commercial agency registration with the Ministry of Commerce.
Post-market surveillance, vigilance and recalls
Authorisation starts the regulatory lifecycle. Manufacturers and their AR are expected to monitor devices on the market, report serious incidents and field safety corrective actions to SFDA within the set timelines, and cooperate on recalls. Significant changes usually need to be notified, and the MDMA must be renewed before it expires.
- Maintain a post-market surveillance plan and complaint handling that covers Saudi Arabia
- Tell your AR quickly about field safety notices issued in other markets
- Track certificate and MDMA expiry dates so renewals are filed on time
How RDO helps
RDO coordinates the path from classification to authorisation. We review your portfolio, confirm the likely class and pathway, help structure the Authorized Representative role, organise the technical file and Arabic labelling, follow up on the GHAD submission and SFDA queries, and support importer licensing. For Korean, Turkish, Chinese and Japanese manufacturers we bridge your regulatory team, Saudi partners and SFDA. Our glossary explains common Saudi regulatory terms.
